Cognitive-behavioral therapy for the treatment of depression and adherence in patients with type 1 diabetes: Pilot data and feasibility

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 14, Issue 2, 2012, Pages

  Markowitz, Sarah M ^a   Carper, Matthew M ^c   Gonzalez, Jeffrey S ^b   Delahanty, Linda M ^c   Safren, Steven A ^c  

^a WELLS COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COGNITIVE THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; PILOT STUDY; SELF CARE; SELF REPORT; THERAPY EFFECT; TREATMENT REFUSAL;

CLINICAL PROTOCOLS; COGNITIVE THERAPY; HUMANS; PHOTOTHERAPY; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RESEARCH DESIGN; SEASONAL AFFECTIVE DISORDER; TIME FACTORS; TREATMENT OUTCOME; VERMONT;

EID: 84863993922     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.11m01220     Document Type: Article

References (37)

1. Evans DL, Charney DS. Mood disorders and medical illness: a major public health problem. Biol Psychiatry. 2003;54(3):177-180. PubMeddoi:10.1016/S0006-3223(03)00639-5 Show Abstract
2. Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069-1078. PubMeddoi:10.2337/diacare.24.6.1069 Show Abstract
3. Ali S, Stone MA, Peters JL, et al. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23(11):1165-1173. PubMed doi:10.1111/j.1464-5491.2006.01943.xShow Abstract
4. Barnard KD, Skinner TC, Peveler R. The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabet Med. 2006;23(4):445-448. PubMeddoi:10.1111/j.1464-5491.2006.01814.xShow Abstract
5. Dunbar-Jacob J, Burke LE, Pyczynski S. Clinical assessment and management of adherence to medical regiments. In: Nicassio PM, Smith TW, eds. Managing Chronic Illness: A Biopsychosocial Perspective. Washington, DC: American Psychological Association; 1995. doi:10.1037/10511-009
6. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107. PubMeddoi:10.1001/archinte.160.14.2101 Show Abstract
7. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care. 2009;32(suppl 1):S13-S61. PubMeddoi:10.2337/dc09-S013 Show Abstract
8. Hood KK, Peterson CM, Rohan JM, et al. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009;124(6):e1171-e1179. PubMed doi:10.1542/peds.2009-0207 Show Abstract
9. Zhang X, Norris SL, Gregg EW, et al. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005;161(7):652-660. PubMeddoi:10.1093/aje/kwi089 Show Abstract
10. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005;28(6):1339-1345. PubMeddoi:10.2337/diacare.28.6.1339 Show Abstract
11. de Groot M, Anderson RJ, Freedland KE, et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63(4):619-630. PubMed Show Abstract
12. Simon GE, Katon WJ, Lin EH, et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry. 2005;27(5):344-351. PubMeddoi:10.1016/j.genhosppsych.2005.04.008Show Abstract
13. Ludman EJ, Katon WJ, Russo JE, et al. Depression and diabetes symptom burden. Gen Hosp Psychiatry. 2004;26(6):430-436. PubMeddoi:10.1016/j.genhosppsych.2004.08.010Show Abstract
14. Kohen D, Burgess AP, Catalán J, et al. The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus. Qual Life Res. 1998;7(3):197-204. PubMed doi:10.1023/A:1008817812520Show Abstract
15. Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23(7):934-942. PubMeddoi:10.2337/diacare.23.7.934 Show Abstract
16. Van Tilburg MAL, McCaskill CC, Lane JD, et al. Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med. 2001;63(4):551-555. PubMed Show Abstract
17. Ciechanowski PS, Katon WJ, Russo JE, et al. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25(4):246-252. PubMed doi:10.1016/S0163-8343(03)00055-0Show Abstract
18. Gendelman N, Snell-Bergeon JK, McFann K, et al. Prevalence and correlates of depression in individuals with and without type 1 diabetes. Diabetes Care. 2009;32(4):575-579. PubMeddoi:10.2337/dc08-1835 Show Abstract
19. Markowitz SM, Gonzalez JS, Wilkinson JL, et al. A review of treating depression in diabetes: emerging findings. Psychosomatics. 2011;52(1):1-18. PubMed Show Abstract
20. Rosello JM, Jimenez-Chaffey MI. Cognitive-behavioral group therapy for depression in adolescents with diabetes: a pilot study. Rev Interam Psicol. 2006;40:219-226.
21. Georgiades A, Zucker N, Friedman KE, et al. Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med. 2007;69(3):235-241. PubMeddoi:10.1097/PSY.0b013e318042588d Show Abstract
22. Safren SA, O'Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28(1):1-10. PubMed doi:10.1037/a0012715Show Abstract
23. Gonzalez JS, McCarl LA, Wexler DD, et al. Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD) in type 2 diabetes. J Cogn Psychother. 2010;24(4):329-343. doi:10.1891/0889-8391.24.4.329
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
25. Nathan DM, Singer DE, Hurxthal K, et al. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med. 1984;310(6):341-346. PubMed doi:10.1056/NEJM198402093100602Show Abstract
26. Singer DE, Coley CM, Samet JH, et al. Tests of glycemia in diabetes mellitus: their use in establishing a diagnosis and in treatment. Ann Intern Med. 1989;110(2):125-137. PubMedShow Abstract
27. Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86-94. PubMed doi:10.1007/s10461-007-9261-4 Show Abstract
28. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57. PubMed Show Abstract
29. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. PubMeddoi:10.1192/bjp.134.4.382 Show Abstract
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. PubMed doi:10.1136/jnnp.23.1.56Show Abstract
31. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401. doi:10.1177/014662167700100306
32. Guy W. Clinical global impressions. In: New Clinical Drug Evaluation Unit (ECDEU) Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental health, Psychopharmacology Research Brand, Division of Extramural Research Programs; 1976: 218-222.
33. Safren SA, Gonzalez JS, Soroudi N. Coping With Chronic Illness: A Cognitive-Behavioral Therapy Approach for Adherence and Depression: Therapist Guide. New York, NY: Oxford University Press; 2007.
34. Safren SA, Gonzalez JS, Soroudi N. Coping With Chronic Illness: A Cognitive-Behavioral Therapy Approach for Adherence and Depression: Workbook. New York, NY: Oxford University Press; 2007.
35. Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39(10):1151-1162. PubMed doi:10.1016/S0005-7967(00)00091-7Show Abstract
36. Helgeson VS, Honcharuk E, Becker D, et al. A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency. Pediatr Diabetes. 2011;12(1):25-30. PubMeddoi:10.1111/j.1399-5448.2010.00663.xShow Abstract
37. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988.